Szmit , S., W. W. Jędrzejczak, and G. Opolski. “Consensus Statement on Indications for the Use of Non-Pegylated Liposomal Doxorubicin in Patients With Lymphomas and Concomitant Cardiovascular Diseases”. OncoReview, Vol. 3, no. 3(11), Oct. 2013, pp. 213-5, https://journalsmededu.pl/index.php/OncoReview/article/view/345.